Aberrant Immunophenotypes Detected by Flow Cytometry in Acute Lymphoblastic Leukemia

References

• Jennings C. D., Foon K. A. Recent advances in flow cytometry. Application to the diagnosis of hematologic malignancies. Blood 1997; 90: 2863–2892
   PubMed Web of Science ®Google Scholar
• Bene M. C., Castoldi G., Knapp W., Ludwig W. D., Matutes E., Orfao A., Van't Veer M. B. Proposals for the immunological classification of acute leukemias. Leukemia 1995; 9: 1783–1786
   PubMed Web of Science ®Google Scholar
• Foon K. A., Tood R. F. Immunologic classification of leukemia and lymphoma. Blood 1986; 68: 1–31
   PubMed Web of Science ®Google Scholar
• Pui C. H., Evans W. E. Acute lymphoblastic leukemia. N Eng J Med 1998; 9: 605–615
   Google Scholar
• Ciudad J., San Miguel J. F., López-Berges M. C., Vidriales B., Valverde B., Ocqueteau M., Mateos G., Caballero M. D., Hernández J., Moro M. J., Mateos M. V., Orfao A. Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia. J Clin Oncol 1998; 16: 3774–3781
   PubMed Web of Science ®Google Scholar
• Boucheix C., David B., Sebban C., Racadot E., Bené M. C., Bernard A., Campos L., Jouault H., Sigaux F., Lepage E., Hervé P., Fière D. Immunophenotype of adult acute lymphoblastic leukemia. Clinical parameters, and outcome: An analysis of a prospective trial including 562 patients (LALA87). Blood 1994; 84: 1603–1612
   PubMed Web of Science ®Google Scholar
• Ryan D. H., Chapplé C., Kossover S. A., Sandberg A., A Cohen H. J. Phenotypic similarities and differences between cALLA-positive acute lymphoblastic leukemia cells and normal marrow cALLA-positive B cell precursors. Blood 1987; 70: 814–821
   PubMed Web of Science ®Google Scholar
• Campana D., Coustan-Smith E., Janossy G. The immunologic detection of minimal residual disease in acute leukemia. Blood 1990; 76: 163–171
   PubMed Web of Science ®Google Scholar
• Campana D., Pui C. H. Detection of minimal residual disease in acute leukemia: methodological advances and clinical significance. Blood 1995; 85: 1416–1434
   PubMed Web of Science ®Google Scholar
• Van Dongen J. J., Breit T. M., Adriaansen H. J., Beishuizen A., Hooijkaas H. Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction. Leukemia 1992; 6(Supp 1)47–59
   PubMedGoogle Scholar
• Campana D., Freitas R. O., Coustan-Smith E. Detection of residual leukemia with immunologic methods: technical developments and clinical implications. Leuk Lymphoma 1994; 13(Supp 1)31–34
   PubMed Web of Science ®Google Scholar
• Ciudad J., Orfao A., Vidriales B., Macedo A., Martinez A., Gonzalez M., López-Berges M. C., Valverde B., San Miguel J. F. Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection. Haematologica 1998; 83: 1069–1075
   PubMed Web of Science ®Google Scholar
• Macedo A., Orfao A., Ciudad J., Gonzalez M., Vidriales B., López-Verges M. C., Martínez A., Landolfi C., Cañizo C., San Miguel J. F. Phenotypic analysis of CD34 subpopulations in normal human bone marrow and its implication for the detection of minimal residual disease. Leukemia 1995; 9: 1896–1901
   PubMed Web of Science ®Google Scholar
• Drach J., Drach D., Glassl H., Gattringer C., Huber H. Flow cytometric determination of atypical antigen expression in acute leukemia for the study of minimal residual disease. Cytometry 1992; 13: 893–901
   PubMedGoogle Scholar
• Gore S. D., Kastan M. B., Goodman S. N., Civin C. I. Detection of minimal residual T cells acute lymphoblastic leukemia by flow cytometry. J Immunol Methods 1990; 132: 275–286
   PubMed Web of Science ®Google Scholar
• Campana D., Coustan-Smith E., Behm F. G. The definition of remission in acute leukemia with immunologic techniques. Bone Marrow Transplant 1991; 8: 429–437
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A.G., Gralnick H. R., Sultan C. Proposals for the classification of acute leukemias. A report of the French-American-British Cooperative Group. Br J Haematol 1976; 33: 451–458
   PubMed Web of Science ®Google Scholar
• Knapp W., Strobl H., Majdic O. Flow cytometric analysis of cell-surface and intracellular antigens in leukemia diagnosis. Cytometry (Communications in Clinical Cytometry) 1994; 18: 187–198
   Web of Science ®Google Scholar
• Terstappen L. W., Mickaels R. A., Dost R., Loken M. R. Increased light scattering resolution facilitates multidimensional flow cytometric analysis. Cytometry 1990; 11: 506–512
   PubMedGoogle Scholar
• Terstappen L. W., Safford M., Konemann S., Loken M. R., Zurlutter K., Büchner T., Hiddemann W., Wörmann B. Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis. Leukemia 1991; 9: 757–767
   Google Scholar
• Griesinger F., Pirò-Noack M., Falk M., Renziehausen A., Troff C., Grove D., Schnittger S., Büchner T., Ritter J., Hiddemann W., Wörmann B. Leukaemia-associated immunophenotypes (LAIP) are observed in 90% of adult and childhood acute lymphoblastic leukaemia: detection in remission marrows predicts outcome. Br J Haematol 1999; 105: 241–255
   PubMed Web of Science ®Google Scholar
• Hann J. M., Richards S. M., Eden O. B., Hill F. G.H. Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom acute lymphoblatic leukaemia trial XI (MRC UKALLXI). Leukemia 1998; 12: 1249–1255
   PubMed Web of Science ®Google Scholar
• Boldt D. H., Kopecky K. J., Head D., Gehly G., Radich J. P., Appelbaum F. R. Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adults. The southwest oncology group experience. Leukemia 1994; 8: 2118–2126
   PubMed Web of Science ®Google Scholar
• Ludwig W. D., Harbott J., Rieder H. Incidence, biologic features and treatment outcome of myeloid-antigen-positive acute lymphoblastic leukemia (My+ ALL). Acute leukemias III. Prognostic factors and treatment strategies, T. Büchner, W. Hiddemann, B. Wörmann, G. Schellong, J. Ritter. Springer, Heidelber 1994; 24–32
   Google Scholar
• Tritz D., Pettigrew A., Talkington S., Smith L., Jennings C. D. Association of CD15 expression and Hq23 translocation in acute leukemias. Mod Pathol 1995; 8: 122A
   Google Scholar
• Hurwitz C. A., Gore S. D., Stone K. D., Civin C. I. Flow cytometric detection of rare normal human marrow cells with immunophenotypes characteristics of acute lymphoblastic leukemia cells. Leukemia 1992; 6: 233–239
   PubMed Web of Science ®Google Scholar
• Lavabre-Bertrand T., Janossy G., Ivory K., Peters R., Seeker-Walker L., Porwit-MacDonald A. Leukemia-associated changes identified by quantitative flow cytometry: I. CD10 expression. Cytometry (Communications in Clinical Cytometry) 1994; 18: 209–217
   Web of Science ®Google Scholar
• Bengtsson M., Smedmyr B., Festin R., Oberg G., Simonsson B., Totterman T. H. B lymphocyte regeneration in marrow and blood after autologous bone marrow transplantation. Increased number of B cells carrying activation and progression markers. Leuk Res 1989; 13: 791–795
   PubMed Web of Science ®Google Scholar
• Campana D., Thompson J. S., Amlot P., Brown S., Janossy G. The cytoplasmic expression of CD3 antigens in normal and malignant cells of the T lymphoid lineage. J Immunol 1987; 138: 648–655
   PubMed Web of Science ®Google Scholar
• Coustan-Smith E., Behm F. G., Sánchez J., Boyett J. M., Hancock M. L., Raimondi S. C., Rubnitz J. E., Rivera G. K., Sandlund J. T., Pui Ch., Campana D. Immunological detection of minimal residual disease in children with acute lymphoblastic leukemia. Lancet 1998; 351: 550–554
   PubMed Web of Science ®Google Scholar
• Farahat N., Morilla A., Owusu-Ankomah K., Morilla R., Ross Pinkerton C., Treleaven J., Matutes E., Powles R., Catovsky D. Detection of minimal residual disease in B-lineage acute lymphoblastic leukaemia by quantitative flow cytometry. Br J Haematol 1998; 101: 158–164
   PubMed Web of Science ®Google Scholar
• Farahat N., Lens D., Morilla R., Matutes E., Catovsky D. Quantitative flow cytometry can distinguish between normal and leukaemic B-cell precursors. Br J Haematol 1995; 91: 640–646
   PubMed Web of Science ®Google Scholar